News
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Darktrace plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
DGAP-News: Mynaric hires veteran laser communications executive Mustafa Veziroglu as President of Mynaric
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Chelverton UK Dividend Trust plc: PDMR Shareholding
Chelverton UK Dividend Trust plc: Net Asset Value(s)
NICE Reports 16% Growth in Total Revenue and 28% Cloud Revenue Growth for the Second Quarter of 2022
NICE (NASDAQ: NICE) today announced results for the second quarter ended June 30, 2022.
Second Quarter 2022 Financial Highlights
GAAP
Non-GAAP
Total revenue of $530.6 million,
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Enterprise Need for Speed Drives U.K. Cloud Growth
A growing number of enterprises in the U.K. are seeking managed cloud services with fast, low-latency links to global communications hubs, according to a new research report published today by
DGAP-News: SGT German Private Equity GmbH & Co. KGaA: SGT German Private Equity redeems 11 million treasury shares
Designated Person Notification
DGAP-News: Deutsche Familienversicherung delivering profitability and innovation
SThree: Block Listing of Shares
EQS-News: PJSC Mechel : MECHEL REPORTS 1H2022 OPERATIONAL RESULTS
DGAP-News: audius SE: audius with significant increase in total output and earnings - increase in sales and earnings forecast
Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that England’s National Institute for Health and Care Excellence (NICE) has recommended Tavneos® in combination with a